Replies to post #31063 on MannKind Corp. (MNKD)

[SidVicious]

WHAT! They had to do it again!?!?! Why? Why was it rejected the first time? This now delays approval to sell in Brazil!!!!

[parkourstar]

Yeah, it was submitted a year ago -- thanks for the ancient history.

More important to MNKD investors is the fact that Biomm is a tiny biotech operation that survives quarter to quarter on secondary offerings; so the question is how does anyone expect them to distribute and sell afrezza -- who's going to pay for it?